Elizabeth Kelly

10PUBLICATIONS
57CO-AUTHORS
Nanotoxicology, health and safetyInnate immunityPredictive and prognostic markersSpeciation and extinctionNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 06, 2026
Reliability of RSV Antigen Diagnostic Tests in the Presence of Nirsevimab.

Sarah R Sincero, Kelly Ann Mahool, Emma Schaefer

|Dec 10, 2024
Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY).

Doug Arbetter, Vancheswaran Gopalakrishnan, Anastasia A Aksyuk

|Aug 29, 2024
Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study.

Kathryn Shoemaker, Karina Soboleva, Angela Branche

|Apr 10, 2024
The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus.

Annefleur C Langedijk, Bram Vrancken, Robert Jan Lebbink

|Apr 08, 2024
Author Correction: Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials.

Bahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk

|Jul 19, 2023
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials.

Bahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk

Pageof 2

Frequent Collaborators

4 joint publications

Michael E Abram

3 joint publications

Ron Dagan

3 joint publications

Anastasia A Aksyuk

3 joint publications

Johnathan D Guest